The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based Study

The Bacillus Calmette–Guérin (BCG) vaccine affords indirect protection against COVID-19, which is presumably due to priming of the innate immune system. It was hypothesized that the live attenuated Varicella Zoster (LAVZ) vaccine, recommended for the elderly population, would also protect against CO...

Full description

Bibliographic Details
Main Authors: Eugene Merzon, Ilan Green, Eli Somekh, Shlomo Vinker, Avivit Golan-Cohen, Ariel Israel, Alessandro Gorohovski, Milana Frenkel-Morgenstern, Michal Stein
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/1/74
_version_ 1797489870602502144
author Eugene Merzon
Ilan Green
Eli Somekh
Shlomo Vinker
Avivit Golan-Cohen
Ariel Israel
Alessandro Gorohovski
Milana Frenkel-Morgenstern
Michal Stein
author_facet Eugene Merzon
Ilan Green
Eli Somekh
Shlomo Vinker
Avivit Golan-Cohen
Ariel Israel
Alessandro Gorohovski
Milana Frenkel-Morgenstern
Michal Stein
author_sort Eugene Merzon
collection DOAJ
description The Bacillus Calmette–Guérin (BCG) vaccine affords indirect protection against COVID-19, which is presumably due to priming of the innate immune system. It was hypothesized that the live attenuated Varicella Zoster (LAVZ) vaccine, recommended for the elderly population, would also protect against COVID-19 infection. A retrospective population-based cross-sectional study was conducted using the Leumit Health Services (LHS) database. LAVZ-vaccinated patients were matched with controls based on a propensity score model using 1:9 nearest-neighbor matching. Matching was based on age, gender, and the presence of some chronic disorders, which were selected according to their association with COVID-19 infection. Multivariate logistic regression analyses, adjusted for sex, age, smoking status, comorbidities, and chronic medications associated with COVID-19 risk, were used to estimate the association between LAVZ vaccination and COVID-19 RT-PCR results. Subjects (625) vaccinated with LAVZ and RT-PCR-tested for COVID-19 were identified. After 1:9 matching of subjects who received the LAVZ vaccine, 6250 subjects were included in the study. Multivariate logistic regression analysis demonstrated a significant and independent negative association between having received the LAVZ vaccine and the likelihood of COVID-19 infection (adjusted OR = 0.47 (95% CI 0.33–0.69, <i>p</i> < 0.001)). This association was further strengthened after separate analysis based on the time of LAVZ vaccination before COVID-19 RT-PCR testing. Individuals aged ≥50 years vaccinated with LAVZ had a decreased likelihood of being tested positive for COVID-19.
first_indexed 2024-03-10T00:22:49Z
format Article
id doaj.art-6c59f5e591f04ac7ba5c7a98ffd0b823
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T00:22:49Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-6c59f5e591f04ac7ba5c7a98ffd0b8232023-11-23T15:38:59ZengMDPI AGVaccines2076-393X2022-01-011017410.3390/vaccines10010074The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based StudyEugene Merzon0Ilan Green1Eli Somekh2Shlomo Vinker3Avivit Golan-Cohen4Ariel Israel5Alessandro Gorohovski6Milana Frenkel-Morgenstern7Michal Stein8Leumit Health Services, Tel Aviv 6473817, IsraelLeumit Health Services, Tel Aviv 6473817, IsraelDepartment of Paediatrics, Mayanei Hayeshuah Medical Centre, Bnei Brak 5154475, IsraelLeumit Health Services, Tel Aviv 6473817, IsraelLeumit Health Services, Tel Aviv 6473817, IsraelLeumit Health Services, Tel Aviv 6473817, IsraelAzrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, IsraelAzrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, IsraelInfectious Disease and Infection Control Unit, Hillel Yaffe Medical Center, Hadera 38100, IsraelThe Bacillus Calmette–Guérin (BCG) vaccine affords indirect protection against COVID-19, which is presumably due to priming of the innate immune system. It was hypothesized that the live attenuated Varicella Zoster (LAVZ) vaccine, recommended for the elderly population, would also protect against COVID-19 infection. A retrospective population-based cross-sectional study was conducted using the Leumit Health Services (LHS) database. LAVZ-vaccinated patients were matched with controls based on a propensity score model using 1:9 nearest-neighbor matching. Matching was based on age, gender, and the presence of some chronic disorders, which were selected according to their association with COVID-19 infection. Multivariate logistic regression analyses, adjusted for sex, age, smoking status, comorbidities, and chronic medications associated with COVID-19 risk, were used to estimate the association between LAVZ vaccination and COVID-19 RT-PCR results. Subjects (625) vaccinated with LAVZ and RT-PCR-tested for COVID-19 were identified. After 1:9 matching of subjects who received the LAVZ vaccine, 6250 subjects were included in the study. Multivariate logistic regression analysis demonstrated a significant and independent negative association between having received the LAVZ vaccine and the likelihood of COVID-19 infection (adjusted OR = 0.47 (95% CI 0.33–0.69, <i>p</i> < 0.001)). This association was further strengthened after separate analysis based on the time of LAVZ vaccination before COVID-19 RT-PCR testing. Individuals aged ≥50 years vaccinated with LAVZ had a decreased likelihood of being tested positive for COVID-19.https://www.mdpi.com/2076-393X/10/1/74COVID-19 infectionlive-attenuated zoster vaccine
spellingShingle Eugene Merzon
Ilan Green
Eli Somekh
Shlomo Vinker
Avivit Golan-Cohen
Ariel Israel
Alessandro Gorohovski
Milana Frenkel-Morgenstern
Michal Stein
The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based Study
Vaccines
COVID-19 infection
live-attenuated zoster vaccine
title The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based Study
title_full The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based Study
title_fullStr The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based Study
title_full_unstemmed The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based Study
title_short The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based Study
title_sort association of previous vaccination with live attenuated varicella zoster vaccine and covid 19 positivity an israeli population based study
topic COVID-19 infection
live-attenuated zoster vaccine
url https://www.mdpi.com/2076-393X/10/1/74
work_keys_str_mv AT eugenemerzon theassociationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT ilangreen theassociationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT elisomekh theassociationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT shlomovinker theassociationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT avivitgolancohen theassociationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT arielisrael theassociationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT alessandrogorohovski theassociationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT milanafrenkelmorgenstern theassociationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT michalstein theassociationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT eugenemerzon associationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT ilangreen associationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT elisomekh associationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT shlomovinker associationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT avivitgolancohen associationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT arielisrael associationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT alessandrogorohovski associationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT milanafrenkelmorgenstern associationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy
AT michalstein associationofpreviousvaccinationwithliveattenuatedvaricellazostervaccineandcovid19positivityanisraelipopulationbasedstudy